This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Bird Savings and Poster Submission Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
September 27-30, 2022
Boston Convention and Exhibition CenterBoston, MA

Ian P Goodwin
Director, Program Design at Fujifilm Diosynth Biotechnologies


Ian Goodwin is a Director in the Viral Gene Therapy Global Program Design team at FUJIFILM Diosynth Biotechnology (FDB), based in College Station, Texas. He has been at FDB for five years, having also served as Associate Principal Scientist Group Leader in the Process Development group. Ian is currently responsible for providing technical and project scope development support to prospective clients engaged in CDMO selection for viral and non-viral cell & gene therapy products. Ian’s previous experience includes nine years working on the process development and manufacturing of adeno-associated virus (AAV) and lentivirus vectors (LV) in academic, start-up, and CDMO environments. Ian holds a Master’s Degree in Microbiology and Immunology from Drexel University College of Medicine and a B.Sc in Microbiology from The University of Pittsburgh.

Agenda Sessions

  • Scientific Track Presentation